Genetic Abnormalities of Lung Cancer
Genetic mutations that are known to play critical roles in the development and progression of NSCLC include:
- Epidermal growth factor receptor (EGFR) – the EGFR gene is responsible for a protein that helps a cell respond to its environment and can trigger cell growth, division, and survival.
- KRAS – the KRAS gene is involved in regulating cell division.
- Anaplastic lymphoma kinase (ALK) – the ALK gene provides instructions for a protein that plays an important role in cell growth, division, and maturation.
- Epidermal Growth Factor Receptor (EGFR)
- Kirsten RAS (KRAS)
- Anaplastic Lymphoma Kinase (ALK)
- Other Genetic Abnormalities in NSCLC
Related Conference of Genetic Abnormalities of Lung Cancer
April 13-14, 2026
23rd International Conference on Breast Pathology and Cancer Diagnosis
Tokyo, Japan
September 29-30, 2026
5th Experts Meeting on Cancer Medicine, Radiology & Treatment
Aix-en-Provence, France
Genetic Abnormalities of Lung Cancer Conference Speakers
Recommended Sessions
- Alpha-1 Anti Trypsin Deficiency
- ARDS of Lung Cancer
- Awareness and Prevention of Lung Cancer
- Biomarkers of NSCLC
- Bronchial Adenoma
- Chemotherapy for Lung Cancer
- Classification of Lung Cancer
- Diagnostic Evaluation of Lung Cancer
- Genetic Abnormalities of Lung Cancer
- Immunotherapy for Lung Cancer
- Lung Cancer Surgery
- Lung Disease and Respiratory Health
- Molecular Background of Lung Cancer
- Pediatric Lung Cancer
- Radiotherapy for Lung Cancer
- Risk Factors and Symptoms of Lung Cancer
- Screening of Lung Cancer
- Targeted Therapy for Lung Cancer
Related Journals
Are you interested in
- Advancement in the Field of Cancer - CANCER THERAPY MEETING 2026 (France)
- Advances in Breast Cancer Diagnosis - Breast Cancer Summit 2026 (France)
- Advances in Immuno-Oncology - CANCER THERAPY MEETING 2026 (France)
- Advances in Pediatric Oncology Imaging & Therapy - Cancer Meeting Summit 2026 (France)
- Advances in Supportive Care and Symptom Management - CANCER THERAPY MEETING 2026 (France)
- AI and Machine Learning in Cancer Diagnosis - Cancer Meeting Summit 2026 (France)
- AI-Driven Treatment Planning and Workflow Optimization - Cancer Meeting Summit 2026 (France)
- Alternative Treatments and Therapeutics - Cancer Science 2026 (UAE)
- Artificial Intelligence & Big Data in Breast Oncology - Breast Cancer Summit 2026 (France)
- Artificial Intelligence and Big Data in Cancer Research - CANCER THERAPY MEETING 2026 (France)
- Artificial Intelligence in Breast Imaging - Breast Cancer-2026 (Italy)
- Breakthroughs in Precision Cancer Treatments - Cancer Meeting Summit 2026 (France)
- Breast Cancer - Cancer Science 2026 (UAE)
- Breast Cancer and Cell Biology - Breast Cancer 2026 (UAE)
- Breast Cancer and Immunology - Breast Cancer 2026 (UAE)
- Breast Cancer and Pregnancy - Breast Cancer Summit 2026 (France)
- Breast Cancer Awareness - Breast Cancer 2026 (UAE)
- Breast Cancer Biomarkers and Prognosis - Breast Cancer-2026 (Italy)
- Breast Cancer Clinical Trials - Breast Cancer 2026 (UAE)
- Breast Cancer Detection, Prevention, and Diagnosis - Breast Cancer 2026 (UAE)
- Breast Cancer Imaging and Radiology - Breast Cancer Summit 2026 (France)
- Breast Cancer in Men - Breast Cancer Summit 2026 (France)
- Breast Cancer in Men - Breast Cancer-2026 (Italy)
- Breast Cancer in Young Women - Breast Cancer Summit 2026 (France)
- Breast Cancer Management - Breast Cancer 2026 (UAE)
- Breast Cancer Nursing - Breast Cancer 2026 (UAE)
- Breast Cancer Prevention and Lifestyle - Breast Cancer Summit 2026 (France)
- Breast Cancer Prevention Strategies - Breast Cancer-2026 (Italy)
- Breast Cancer Risk - Breast Cancer 2026 (UAE)
- Breast Cancer Staging - Breast Cancer 2026 (UAE)
- Breast Cancer Surgery - Breast Cancer 2026 (UAE)
- Breast Cancer Survivorship and Quality of Life - Breast Cancer-2026 (Italy)
- Breast Cancer Types and Etiology - Breast Cancer 2026 (UAE)
- Breast Reconstruction and Cosmetic Outcomes - Breast Cancer Summit 2026 (France)
- Breast Reconstruction and Cosmetic Surgery - Breast Cancer-2026 (Italy)
- Cancer Care in the Era of Digital Health - CANCER THERAPY MEETING 2026 (France)
- Cancer Cell Biology & Genetics - Cancer Meeting Summit 2026 (France)
- Cancer Control and Prevention - Cancer Science 2026 (UAE)
- Cancer Early Detection, Diagnosis and Prognosis - Cancer Meeting Summit 2026 (France)
- Cancer Epidemiology and Prevention - CANCER THERAPY MEETING 2026 (France)
- Cancer Epigenetics - Cancer Science 2026 (UAE)
- Cancer Genomics & Metabolomics - CANCER THERAPY MEETING 2026 (France)
- Cancer Immunology - CANCER THERAPY MEETING 2026 (France)
- Cancer Metabolism and Therapeutic Interventions - CANCER THERAPY MEETING 2026 (France)
- Cancer Metastasis - Cancer Science 2026 (UAE)
- Cancer Science - Cancer Science 2026 (UAE)
- Cancer Screening & Chemotherapy - Cancer Meeting Summit 2026 (France)
- Cancer Stem Cells: Understanding and Targeting - CANCER THERAPY MEETING 2026 (France)
- Cancer Survivorship and Quality of Life - CANCER THERAPY MEETING 2026 (France)
- Cancer Vaccines - CANCER THERAPY MEETING 2026 (France)
- Cancer Vaccines - Cancer Meeting Summit 2026 (France)
- Cancers Biomarkers - Cancer Science 2026 (UAE)
- Cancers Pharmacology - Cancer Science 2026 (UAE)
- Case Studies - Breast Cancer 2026 (UAE)
- Cell-Based Therapy - CANCER THERAPY MEETING 2026 (France)
- Clinical Trials and New Drug Development - CANCER THERAPY MEETING 2026 (France)
- Diet and Lifestyle Effects on Breast Cancer - Breast Cancer 2026 (UAE)
- DNA Damage, Mutation and Cancer - Cancer Meeting Summit 2026 (France)
- Drug Resistance and Overcoming Challenges - CANCER THERAPY MEETING 2026 (France)
- Early Detection and Biomarker-Driven Care - Cancer Meeting Summit 2026 (France)
- Emerging Radiopharmaceuticals and Molecular Imaging - Cancer Meeting Summit 2026 (France)
- Epidemiology of Breast Cancer and Risk Factors - Breast Cancer 2026 (UAE)
- Ethical and Regulatory Issues in Cancer Research - CANCER THERAPY MEETING 2026 (France)
- Future Directions in Cancer Therapy and Research - CANCER THERAPY MEETING 2026 (France)
- Genetic Predisposition and BRCA Mutations - Breast Cancer Summit 2026 (France)
- Genomic Profiling for Personalized Cancer Care - Cancer Meeting Summit 2026 (France)
- Global Innovations in Cancer Care Delivery & Accessibility - Cancer Meeting Summit 2026 (France)
- Hematology- Oncology - Cancer Science 2026 (UAE)
- HER2-Positive Breast Cancer - Breast Cancer Summit 2026 (France)
- HER2-Positive Breast Cancer Advances - Breast Cancer-2026 (Italy)
- Hormone Receptor-Positive Breast Cancer - Breast Cancer Summit 2026 (France)
- Hormone Receptor-Positive Subtypes - Breast Cancer-2026 (Italy)
- Immunotherapy and Breast Cancer - Breast Cancer-2026 (Italy)
- Immunotherapy and Novel Therapeutic Approaches - Cancer Meeting Summit 2026 (France)
- Immunotherapy in Breast Cancer - Breast Cancer-2026 (Italy)
- Improved Survivorship Care and Quality-of-Life Strategies - Cancer Meeting Summit 2026 (France)
- Inflammatory Breast Cancer - Breast Cancer 2026 (UAE)
- Innovations in Breast Cancer Treatment - Breast Cancer Summit 2026 (France)
- Innovations in Cancer Data and Informatics - CANCER THERAPY MEETING 2026 (France)
- Innovative Approaches in Cancer Radiology - CANCER THERAPY MEETING 2026 (France)
- Integrating Multidisciplinary Strategies in Cancer Care - Cancer Meeting Summit 2026 (France)
- Integration of Patient-Reported Outcomes in Cancer therapy - CANCER THERAPY MEETING 2026 (France)
- Integrative Oncology for Holistic Patient Support - Cancer Meeting Summit 2026 (France)
- Liquid Biopsies and Non-Invasive Diagnostic Tools - Cancer Meeting Summit 2026 (France)
- Liquid Biopsy and Early Cancer Detection - CANCER THERAPY MEETING 2026 (France)
- Liquid Biopsy and Non-Invasive Diagnostics - Breast Cancer-2026 (Italy)
- Male Breast Cancer Research - Breast Cancer 2026 (UAE)
- Mammography - Breast Cancer 2026 (UAE)
- Metastatic Breast Cancer Management - Breast Cancer-2026 (Italy)
- Minimally Invasive Image-Guided Interventions - Cancer Meeting Summit 2026 (France)
- Molecular Diagnostics and Biomarkers in Cancer - CANCER THERAPY MEETING 2026 (France)
- Nanotechnology in Cancer Diagnosis and Treatment - CANCER THERAPY MEETING 2026 (France)
- Neoadjuvant and Adjuvant Therapies - Breast Cancer-2026 (Italy)
- Neonatal & Pediatric Oncology - Cancer Meeting Summit 2026 (France)
- Next-Generation Imaging & Radiology Techniques - Cancer Meeting Summit 2026 (France)
- Oncogenomics - Cancer Science 2026 (UAE)
- Oncology Nursing and Care - Cancer Science 2026 (UAE)
- Oncology Nursing: Advancements in Patient Care - CANCER THERAPY MEETING 2026 (France)
- Oncology Radiology, Nanotechnology - Cancer Meeting Summit 2026 (France)
- Organic Specific Cancer - Cancer Science 2026 (UAE)
- Pediatric Cancer Research and Therapeutics - CANCER THERAPY MEETING 2026 (France)
- Personalized Medicine & Targeted Therapies - Cancer Meeting Summit 2026 (France)
- Psychosocial Aspects of Breast Cancer - Breast Cancer-2026 (Italy)
- Psychosocial Support and Survivorship - Breast Cancer Summit 2026 (France)
- Psychotherapy and Cancer - CANCER THERAPY MEETING 2026 (France)
- Radiation Oncology Advances & Safety Innovations - Cancer Meeting Summit 2026 (France)
- Radiation Oncology in Breast Cancer - Breast Cancer-2026 (Italy)
- Radiation Oncology: Innovations and Techniques - CANCER THERAPY MEETING 2026 (France)
- Radiation Therapy in Breast Cancer - Breast Cancer Summit 2026 (France)
- Radiology - Breast Cancer 2026 (UAE)
- Real-Time Tumor Monitoring and Adaptive Therapies - Cancer Meeting Summit 2026 (France)
- Role of Microbiome in Cancer - CANCER THERAPY MEETING 2026 (France)
- Skin Cancer - Cancer Science 2026 (UAE)
- Surgical Innovations in Breast Cancer - Breast Cancer-2026 (Italy)
- Surgical Oncology in Breast Cancer - Breast Cancer Summit 2026 (France)
- Targeted Therapy and Drug Development - Breast Cancer-2026 (Italy)
- Targeted Therapy and Precision Medicine - CANCER THERAPY MEETING 2026 (France)
- Theranostics: Combined Imaging and Treatment Approaches - Cancer Meeting Summit 2026 (France)
- Translational Research for Improved Patient Outcomes - Cancer Meeting Summit 2026 (France)
- Triple-Negative Breast Cancer (TNBC) - Breast Cancer Summit 2026 (France)
- Triple-Negative Breast Cancer Research - Breast Cancer-2026 (Italy)
- Tumor Biology - Cancer Science 2026 (UAE)
- Tumor Microenvironment and Metastasis - CANCER THERAPY MEETING 2026 (France)
- Tumor Virology - Cancer Science 2026 (UAE)
- Young Women and Breast Cancer - Breast Cancer-2026 (Italy)